News: Departments

Lori Stegner has spent most of her life entertaining audiences, starting with family and friends during her childhood.

We’re strong and we’re advancing in our fight against cancer. That’s the feeling permeating Vanderbilt-Ingram Cancer Center, even as the health care industry faces unprecedented financial concerns and we proactively tighten our budgets here at Vanderbilt University Medical Center. I’m reminded of the name of this magazine—Momentum. Every day I can feel the movement and […]

This fall, Anne Washburn and her sister Rachel ran a half marathon in memory of their mother Sharon, who died from pancreatic cancer 25 years ago. “I know 25 years is just a number, but it’s a time of reflection. I’m turning 46 and that’s as long as her life was. I think how thankful […]

• PCORI is an independent, non-profit, non-governmental organization based in Washington, D.C. • The organization helps people make informed health care decisions and improves health care delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers and the broader health care community. • PCORI is funded […]

More than 140,000 genetic mutations have been linked to cancer, but there are only a few dozen approved targeted therapies. A prominent businessman has taken up the challenge to find new targeted therapies by endowing a research fund in cancer drug discovery. Ronald James, president and CEO of James Marine, Inc., established the James Family […]

M y cancer story is not unique, not special in any way. But telling my story is a form of therapy for me—a way to exorcise some of the less pleasant details of an unexpected journey and exalt some important things I learned along the way.

Arteaga to lead major new cancer research initiatives Carlos Arteaga, M.D., Donna S. Hall Professor of Breast Cancer, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer […]

Vanderbilt-Ingram Cancer Center is committed to conducting innovative and high-impact basic, translational and clinical research with the greatest potential for making a difference for cancer patients, today and in the future. Here’s a sampling of work published in peer-reviewed journals by Cancer Center investigators in 2012-2013:   Study identifies new mechanism for cancer development Bhuminder […]

An “undruggable” cancer-causing protein, 30 years of research and the national initiative that aims to finally make the connections

Prostate cancer survivors step into the spotlight to take outcomes research in a new direction.